Delivery Order SPE2DB20D3103-SPE2DB26FL3W7
Award Date 10/27/25
Potential Completion Date 10/28/25
Potential Value $3.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $22,946.07 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhaler medication used to treat chronic obstructive pulmonary disease. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of September 9, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,688.69 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on October 28, 2025, with an ultimate completion date of October 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,176.22 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count). This firm fixed-price, non-set-aside delivery order was awarded on October 17, 2025, with an ultimate completion date of October 20, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $26,582.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The contract was competitively awarded with no set-aside designation and is set for completion by August 4, 2025. This delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a $3,024.00 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,713.88 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, was issued under a firm fixed-price delivery order mechanism with no set-aside designation. This award represents a competitive procurement that leverages...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,350.27 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by August 26, 2025. The award was processed on August 25, 2025, with performance taking place at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $10,252.23 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, which was competitively awarded without set-aside provisions, carries a firm fixed price structure and was finalized on November 4, 2025, with an ultimate completion date of November 5, 2025. The pharmaceutical will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,415.62 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count units) on July 14, 2025, with completion expected by July 15, 2025. This firm fixed price delivery order represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999.999 billion through December 2026. The product is being delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,076.70 to AmerisourceBergen Drug Corp for the supply of TRELEGY ELLIPTA 100-62.5-25, a combination inhalation medication containing fluticasone, umeclidinium, and vilanterol used to treat chronic obstructive pulmonary disease. This firm fixed-price, non-set-aside delivery order was awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's corporate...